Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREIndicated to suppress estrus in mares. Suppression of estrus will also facilitate management of prolonged estrus conditions.
LEARN MORE